OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

Antzeko izenburuak

• In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
  nork: Vasan, Sandhya, et al.
  Argitaratua: (2011)
• Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
  nork: Vasan, Sandhya, et al.
  Argitaratua: (2010)
• A DNA-Based Candidate HIV Vaccine Delivered via In Vivo Electroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers
  nork: Kopycinski, Jakub, et al.
  Argitaratua: (2012)
• Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
  nork: Vasan, Sandhya, et al.
  Argitaratua: (2010)
• Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
  nork: Mpendo, J, et al.
  Argitaratua: (2012)